Product Information

IVABRADINE HCL 5 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.7103 per EA under NDC 31722005360. Its NADAC has been published 108 times since Oct 23, 2024.

FDA first approved this application on Oct 5, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IVABRADINE HCL 5 MG TABLET

Ivabradine
$0.7103per EA

Strength

5 mg/1

NDC

31722005360

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

IVABRADINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213366

FDA Approved

10/5/2022

TE Code

AB

On Market Since

10/5/2022

Pharmacological Classes

Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists
Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker

Price Statistics

The NADAC for IVABRADINE HCL 5 MG TABLET has been published 108 times since Oct 23, 2024, and over the history we have for it it has declined 84.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7103 per EA
All-time high$4.5638 (Nov 13, 2024)
All-time low$0.7103 (Oct 21, 2026)
52-week high$2.8731
52-week low$0.7103
Median price$2.9854
Average price$2.4094
Largest weekly change-40.9% (Feb 18, 2026)
Weeks tracked108
Tracking sinceOct 23, 2024

Price History

1W

0.0%

1M

-6.6%

3M

-7.7%

6M

-9.3%

1Y

-76.2%

3Y

N/A

5Y

N/A

All

-84.4%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IVABRADINE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IVABRADINE HCL 5 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.7103 per EA (NDC 31722005360), effective Nov 11, 2026.

How has the price of IVABRADINE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for IVABRADINE HCL 5 MG TABLET has declined 84.4%. It has been tracked across 108 weekly CMS publications since Oct 23, 2024.

What are the highest and lowest recorded NADAC prices for IVABRADINE HCL 5 MG TABLET?

Since Oct 23, 2024, the NADAC for IVABRADINE HCL 5 MG TABLET has ranged from a low of $0.7103 (Oct 21, 2026) to a high of $4.5638 (Nov 13, 2024), with a median of $2.9854 per EA.

Are there cheaper alternatives to IVABRADINE HCL 5 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IVABRADINE HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures IVABRADINE HCL 5 MG TABLET?

IVABRADINE HCL 5 MG TABLET (NDC 31722005360) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.